Canada is in the midst of negotiations over the Comprehensive Economic and Trade Agreement (CETA) with the European … intellectual property (IP) protection for pharmaceutical innovation. Canada faces pressure to enhance IP protection so that it more … closely aligns with protection that prevails in Europe and the United States, among other nations.The pressure for Canada to …

On 19 December 1997, the EC requested consultations with Canada in respect of the alleged lack of protection of … inventions by Canada in the area of pharmaceuticals under the relevant provisions of the Canadian implementing legislation, in … particular the Patent Act. The EC alleged that Canada’s legislation is not compatible with its obligations under the TRIPS …